ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
פורמט:	Journal article
יצא לאור:	Elsevier 2016

פריטים דומים

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
מאת: Wilson, J, et al.
יצא לאור: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
מאת: Brunner, T, et al.
יצא לאור: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
מאת: Brunner, T, et al.
יצא לאור: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
מאת: Brunner, T, et al.
יצא לאור: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
מאת: Unaí Tupinambás, et al.

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
מאת: Dinler A Antunes, et al.
יצא לאור: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
מאת: Chao Ying, et al.
יצא לאור: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
מאת: Holyoake, D, et al.
יצא לאור: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
מאת: Crosby, T, et al.
יצא לאור: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
מאת: Anjali K. Gupta, et al.
יצא לאור: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
מאת: Pranav Kumar, et al.
יצא לאור: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
מאת: Mukherjee, S, et al.
יצא לאור: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
מאת: Zhongli Liu, et al.
יצא לאור: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
מאת: Ashley Albert, et al.
יצא לאור: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
מאת: André FA Santos, et al.
יצא לאור: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
מאת: Mukherjee, S, et al.
יצא לאור: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
מאת: Al-Assar, O, et al.
יצא לאור: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
מאת: Sudeep Gupta, et al.
יצא לאור: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
מאת: Fokas, E, et al.
יצא לאור: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
מאת: Steffi Liebscher, et al.
יצא לאור: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
מאת: E. P. Solov’eva, et al.
יצא לאור: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
מאת: Christoph Driessen, et al.
יצא לאור: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
מאת: V. B. Denisenko,, et al.
יצא לאור: (2018-12-01)

Chemoradiation of pancreatic carcinoma
מאת: Erdinç Nayır, et al.
יצא לאור: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
מאת: Jean-Guy Baril, et al.
יצא לאור: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
מאת: Camille Bono, et al.
יצא לאור: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
מאת: Hilario Yankey, MD, MBA, et al.
יצא לאור: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
מאת: N. V. Marinichenko, et al.
יצא לאור: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
מאת: K. Vanitha Prakash, et al.
יצא לאור: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
מאת: Alison K. Yoder, et al.
יצא לאור: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
מאת: D. V. Gogolin, et al.
יצא לאור: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
מאת: Léon Juan, et al.
יצא לאור: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
מאת: Rosi Bissinger, et al.
יצא לאור: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
מאת: Lenka Besse, et al.
יצא לאור: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
מאת: Anna Gidari, et al.
יצא לאור: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
מאת: Serena Veschi, et al.
יצא לאור: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
מאת: Kang Young-Nam, et al.
יצא לאור: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
מאת: Hill, E, et al.
יצא לאור: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
מאת: Tinkl, D, et al.
יצא לאור: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
מאת: Camacho Ricardo J, et al.
יצא לאור: (2010-08-01)